{
    "2020-06-08": [
        [
            {
                "time": "",
                "original_text": "大宗交易两重天：涨四倍的妙可蓝多遭34笔折价“甩卖”，机构溢价加仓优质白马（附名单）",
                "features": {
                    "keywords": [
                        "大宗交易",
                        "妙可蓝多",
                        "折价甩卖",
                        "机构溢价加仓",
                        "优质白马"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品饮料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020年6月投资月报：医药的牛市 是从什么时候开始的？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "牛市",
                        "投资月报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：全球疫情持续 API和CDMO二季度超预期机会明显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全球疫情",
                        "API",
                        "CDMO",
                        "二季度超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【兴证医药】CXO（创新药产业链）的过去、现在和未来---医药行业周报",
                "features": {
                    "keywords": [
                        "CXO",
                        "创新药产业链",
                        "医药行业周报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}